Provisio Medical

Provisio Medical is pioneering Sonic Lumen Tomography (SLT IVUS™), a disruptive intravascular ultrasound technology designed to provide real-time, automated measurements of a vessel's blood flow lumen. The platform aims to address the significant shortcomings of the current standard of care, fluoroscopy, by improving sizing accuracy for endovascular devices in peripheral vascular, coronary, neurovascular, and structural heart markets. As a private, pre-revenue company, Provisio is developing a cost-efficient, disposable catheter-based system that integrates into existing clinical workflows and catheters. Its success hinges on clinical validation, regulatory clearance, and market adoption against established imaging competitors.

Sonic Lumen Tomography (SLT IVUS™): A proprietary intravascular ultrasound platform designed to provide automated, real-time measurements of a vessel's blood flow lumen. It uses integrated sensors on therapeutic catheters to eliminate the need for user interpretation and separate imaging catheter pullbacks.

Provisio competes primarily against the dominant fluoroscopy standard of care and, to a lesser extent, established high-resolution imaging technologies like conventional IVUS (Philips, Boston Scientific) and OCT (Abbott). Its differentiation is based on automation, workflow integration, and cost, but it faces significant challenges from these well-capitalized incumbents with deep market penetration.